Loading…

Targeted review of maximum residue levels (MRLs) for endosulfan

In accordance with Article 43 of Regulation (EC) 396/2005, EFSA received a request from the European Commission to review the existing maximum residue levels (MRLs) for the non‐approved active substance endosulfan in view of the possible lowering of the MRLs. EFSA investigated the origin of the curr...

Full description

Saved in:
Bibliographic Details
Published in:EFSA journal 2023-07, Vol.21 (7), p.e08114-n/a
Main Authors: Bellisai, Giulia, Bernasconi, Giovanni, Binaglia, Marco, Carrasco Cabrera, Luis, Castellan, Irene, Castoldi, Anna Federica, Chiusolo, Arianna, Crivellente, Federica, Del Aguila, Monica, Ferreira, Lucien, Santonja, German Giner, Greco, Luna, Istace, Frederique, Jarrah, Samira, Lanzoni, Anna, Leuschner, Renata, Mangas, Iris, Miron, Ileana, Nave, Stefanie, Panzarea, Martina, Parra Morte, Juan Manuel, Pedersen, Ragnor, Reich, Hermine, Ruocco, Silvia, Santos, Miguel, Scarlato, Alessia Pia, Terron, Andrea, Theobald, Anne, Tiramani, Manuela, Verani, Alessia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In accordance with Article 43 of Regulation (EC) 396/2005, EFSA received a request from the European Commission to review the existing maximum residue levels (MRLs) for the non‐approved active substance endosulfan in view of the possible lowering of the MRLs. EFSA investigated the origin of the current EU MRLs. For existing EU MRLs that reflect previously authorised uses in the EU, or that are based on obsolete Codex maximum residue limits, or import tolerances that are not required any longer, EFSA proposed the lowering to the limit of quantification or to an alternative MRL. EFSA performed an indicative chronic and acute dietary risk assessment for the revised list of MRLs to allow risk managers to take the appropriate decisions. For all commodities, further risk management discussions are required to decide which of the risk management options proposed by EFSA should be implemented in the EU MRL legislation.
ISSN:1831-4732
1831-4732
2314-9396
DOI:10.2903/j.efsa.2023.8114